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OBJECTIVES The purpose of this study was to investigate the responses of patients with primary pulmonary
hypertension (PPH) to constant work rate exercise and to examine the effect of nitric oxide
(NO) inhalation.
BACKGROUND Maximal exercise tolerance is reduced in PPH, but gas exchange responses to constant work
rate exercise have not been defined. We hypothesized that increased pulmonary vascular
resistance in PPH would reduce the rate of rise of minute oxygen consumption in response
to a given work rate. Because NO may lower pulmonary vascular pressures in PPH, we also
postulated that inhaled NO might ameliorate gas exchange abnormalities.
METHODS Nine PPH patients and nine matched normal subjects performed 6-min duration constant
work rate cycle ergometry exercise (33.9 6 13.4 W). Patients performed two experiments:
breathing air and breathing air with NO (20 ppm). Preexercise right ventricular systolic
pressure was assessed by Doppler echocardiography. Normal subjects performed the air
experiment only. Gas exchange and heart rate responses were characterized by fitting
monoexponential curves.
RESULTS In PPH patients, resting right ventricular systolic pressure fell after NO inhalation (from
83.8 6 16.9 to 73.9 6 21.6 mm Hg, p , 0.01, analysis of variance with Tukey correction),
but not after breathing air alone (from 88.0 6 20.8 to 86.7 6 20.6 mm Hg, p 5 NS). Nitric
oxide did not affect any of the gas exchange responses. Minute oxygen consumption was
similar by the end of exercise in patients and normals, but increased more slowly in patients
(mean response time [MRT]: air, 63.17 6 14.99 s; NO, 61.60 6 15.45 s) than normals
(MRT, 32.73 6 14.79, p , 0.01, analysis of variance, Tukey test). Minute oxygen
consumption kinetics during recovery were slower in patients (MRT air: 82.50 6 29.94 s;
NO, 73.36 6 15.87 s) than in normals (MRT, 34.59 6 7.11 s, p , 0.01). Heart rate kinetics
during exercise and recovery were significantly slower in patients than in normals.
CONCLUSIONS The cardiac output response is impaired in PPH. Nitric oxide lowered pulmonary artery
pressure at rest, but failed to improve exercise gas exchange responses. (J Am Coll Cardiol
2000;36:547–56) © 2000 by the American College of Cardiology
In patients with primary pulmonary hypertension (PPH),
the initial symptoms are usually related to exertion and this
is reflected in reduced maximal O2 consumption (V˙O2max)
on incremental maximal exercise testing (1,2). Submaximal
exercise testing has also been advocated as a means of
assessing patients with exercise intolerance. Compared with
maximal exercise testing, it is more representative of daily
activity and may be less unpleasant for the patient. In
patients with chronic heart failure due to left ventricular
disease, minute oxygen consumption (V˙O2) has been found
to rise more slowly than normal in response to the same
constant work rate submaximal exercise (3,4). Sietsema (5)
studied a group of patients with pulmonary vascular disease
of mixed etiology performing submaximal exercise and
again found prolonged V˙O2 kinetics. Casaburi et al. (6)
studied a group of patients with complete heart block who
had programmable permanent pacemakers. They found that
V˙O2 rose more quickly in response to the same submaximal
work rate if the pacemaker rate was increased. The pattern
of decline in V˙O2 after cessation of exercise also appears to
be abnormally slow in patients with chronic heart failure
(4,7), but little is known about the recovery phase in PPH.
If V˙O2 kinetics are slowed in response to exercise, the O2
deficit is, by implication, increased. Excess postexercise O2
consumption (EPOC), often referred to as the O2 debt, may
be elevated as a consequence, although the link between O2
deficit during exercise and EPOC has been questioned (8).
Vasodilator drugs have been the mainstay of treatment in
PPH. Nitric oxide (NO) has shown some promise as a
potential therapy. The problem of rapid inactivation of NO
by hemoglobin (9) may be circumvented by inhalation of
NO gas so that it reaches the resistance pulmonary arteries
abluminally. Its subsequent inactivation on reaching the
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circulation eliminates systemic arterial effects (10,11). Using
invasive techniques, previous investigators have found an
acute beneficial effect on pulmonary vascular resistance after
inhalation of NO in PPH (10,12). Hemodynamic changes
are, however, not necessarily correlated with clinical im-
provement in PPH (13) or chronic heart failure (14). The
use of exercise testing may provide information complemen-
tary to hemodynamic measurements (14).
The purpose of the current study was twofold: 1) to
characterize the responses to constant work rate exercise in
a group of patients with PPH compared with a group of
normal subjects, and 2) to test the hypothesis that the acute
administration of inhaled NO as an add-on to current
therapy would improve abnormal exercise responses in
PPH.
METHODS
Subjects. Six women and three men with clinically stable
PPH were studied. The mean duration of disease was 29.3
months (range 5.4–94.3 months). All but one had previ-
ously undergone right heart catheterization that showed
severe elevation of pulmonary arterial pressures (Table 1).
One patient had been found to have arterial desaturation at
rest while at an altitude of 8,000 feet and accordingly had
left atrial, pulmonary venous and femoral arterial blood
sampling performed at the time of catheterization. She was
found to have a patent foramen ovale, and a step-down in
O2 saturation between pulmonary venous blood and sys-
temic arterial blood suggested a right-to-left shunt across
the patent foramen ovale. None of the patients had evidence
of pulmonary embolism on isotope perfusion lung scanning.
All patients were taking one or more drugs for their disease.
Seven patients were being treated with continuous intrave-
nous infusions of prostacyclin (Flolan; Glaxo Wellcome,
Research Triangle Park, North Carolina) at a mean dose of
8.7 ng/kg/min (range 3–20 ng/kg/min) and five were being
treated with diuretics at a mean dose of furosemide of 44 mg
(range 20–80 mg). Four patients were taking calcium
channel antagonists and five were taking digoxin. Drug
therapy was stable for 2 months before the study and for the
duration of the study period. All had tricuspid regurgitation
identifiable by echocardiography.
Nine healthy subjects were recruited. These subjects were
individually matched for age and gender with the PPH
patients. All were active but did not participate in regular
training programs.
Ethical approval for the study was granted by the Harbor-
UCLA Human Subjects Committee. Written informed
consent was given by all subjects. Characteristics of the
subjects are summarized in Table 1.
Experimental protocol. All exercise tests were performed
on an electronically braked cycle ergometer (Quinton
Corival, Seattle, Washington). In five of the patients who
had long distances to travel, all tests were completed on the
same day separated by at least 2 h. In the other four patients,
tests were performed at weekly intervals.
PRELIMINARY INCREMENTAL EXERCISE TEST. Subjects
were familiarized with the apparatus and performed a
continuous incremental symptom-limited maximal test for
determination of V˙O2max and lactic acidosis threshold
(LAT) (Table 1). The incremental work rate was set at
20 W/min in the normal subjects. In the PPH patients, the
probable exercise tolerance was estimated from the clinical
Abbreviations and Acronyms
EPOC 5 excess postexercise oxygen consumption
LAT 5 lactic acidosis threshold
MRT 5 mean response time
NO 5 nitric oxide
PCr 5 phosphocreatine
PPH 5 primary pulmonary hypertension
RVSP 5 right ventricular systolic pressure
SpO2 5 hemoglobin saturation measured by pulse
oximetry
V˙CO2 5 minute carbon dioxide production
V˙E 5 minute ventilation
V˙O2 5 minute oxygen consumption
Table 1. Subject Characteristics and Constant Work Rates Performed
PPH Patients Normal Subjects
Age (yr) 34.9 6 6.7 34.1 6 6.1
Weight (kg) 73.6 6 14.7 70.1 6 10.5
Height (m) 1.70 6 0.08 1.70 6 0.07
Hemoglobin (g/dl) 15.7 6 2.2 14.0 6 1.3
Systolic pulmonary arterial pressure at
right heart catheterization (mm Hg)
96 6 28 (n 5 8) —
Diastolic pulmonary arterial pressure at
right heart catheterization (mm Hg)
44 6 14 (n 5 8) —
Peak work rate (W) 61 6 22 196 6 50
V˙O2max (liters/min) 1.00 6 0.22 2.41 6 0.75
LAT (liters/min) 0.73 6 0.17 1.32 6 0.35
Constant work rate (W) 33.9 6 13.4 33.9 6 13.4
Data are mean 6 SD. Pulmonary artery pressure was measured at right heart catheterization, which was performed during the
initial evaluation and not at the time of the exercise study.
LAT 5 lactic acidosis threshold; PPH 5 primary pulmonary hypertension; V˙O2max 5 maximal oxygen consumption,
measured during symptom-limited maximal exercise.
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history. Based on this estimate, a work rate increment of
either 5 or 10 W/min was individually chosen to prevent
excessively short or long test durations (15). All subjects
were instructed to stop exercise immediately if they experi-
enced dizziness or chest pain. From the test performed by
each PPH patient, a work rate was determined that corre-
sponded to the V˙O2 at the LAT plus 30% of the difference
between the LAT and V˙O2max, i.e.: (V˙O2 at LAT) 1
0.3(V˙O2max 2 (V˙O2 at LAT)). This individualized work
rate (Table 1) was used for each patient-control matched
pair when performing the constant work rate tests described
below.
CONSTANT WORK RATE EXERCISE TESTS. Each patient
subsequently performed two constant work rate tests (sec-
ond and third tests). A Teflon cannula was inserted into an
antecubital vein for measurement of peripheral venous
lactate concentrations. The patient then rested, seated on
the bicycle ergometer. An echocardiogram was performed
for estimation of right ventricular systolic pressure (RVSP)
by Doppler. Echocardiography was performed by the same
operator throughout the study. After the echocardiogram,
the subject began breathing a gas mixture from a large
(140-liter) breathing bag. The gas mixture was compressed
air mixed, using a blender (Bird Instrument Corp., Palm
Springs, California), with either N2 or NO 400 ppm in N2
(Air Liquide, Downey, California). The ratio of compressed
air to either of the other gases was kept constant at 20:1 so
as to obtain NO concentrations of 20 ppm in the breathing
bag. The control situation with pure N2 was needed to
ensure that the small drop in FiO2 was the same in both
tests. The FiO2 was measured continuously at rest and
during exercise by mass spectrometry (see below). In addi-
tion, the FiNO was measured continuously throughout the
NO study using an NO analyzer (Dasibi Environmental,
Glendale, California) to ensure that it did not vary. After
15 min of breathing the gas mixture, the echocardiogram
was repeated. The order in which the two gas mixtures were
breathed was randomized. The patient and echocardiogra-
pher were not told which gas mixture was being breathed.
After breathing the gas mixture for a total of 25 min, the
patient performed a 6-min duration constant work rate test,
followed by 10 min of recovery. The patient continued to
breathe the relevant gas mixture throughout. The patient
began to pedal at the designated work rate immediately
from rest. The work rate was the same for the two tests in
any one individual. The two constant work rate tests when
carried out on the same day were separated by a minimum
of 3 h.
The normal subjects performed only one constant work
rate test at the same absolute work rate as the patient with
whom they were individually matched (see preceding text
and Table 1). Echocardiography was not performed. The
gas mixture was breathed from the breathing bag as above,
but only the compressed air/N2 mixture was used.
Gas exchange measurements. The nose was occluded by a
nose clip and subjects breathed through a mouthpiece,
attached to a volume turbine transducer (Alpha Technolo-
gies, Laguna Niguel, California) for determination of in-
spired and expired volumes. Gas samples were drawn
continuously from a side port of the mouthpiece for analysis
of fractional concentrations of O2, CO2 and N2 by a mass
spectrometer (Perkin-Elmer, Oakbrook, Illinois). The ana-
log signals from the turbine and mass spectrometer were
digitized at a resolution of 50 Hz and read into a PC.
Breath-by-breath values of minute ventilation (V˙E), V˙O2
and CO2 production (V˙CO2) were calculated as previously
described (16).
Echocardiography. Echocardiography was performed us-
ing a phased array ultrasound machine with a 2.5-MHz
transducer (Acuson, Mountain View, California). Paraster-
nal and apical images were obtained with color flow Dopp-
ler to align the continuous-wave Doppler cursor with the
tricuspid regurgitant jet. The RVSP gradient was estimated
using the formula DP 5 4 V2, where DP is the difference
between right ventricular and right atrial pressure, and V is
the velocity of the tricuspid regurgitant jet (17). Right
ventricular systolic pressure was calculated as DP 1 right
atrial pressure. Right atrial pressure was arbitrarily assumed
to be 15 mm Hg.
Analysis of data. To reduce variation in V˙O2 and V˙CO2
resulting from changes in lung volume and alveolar concen-
tration from breath to breath, the alveolar correction of
Beaver et al. (18) was employed. This method corrects the
volume of O2 and CO2 in the alveolar gas for each breath up
or down depending on changes in exhaled N2, O2 and CO2
concentrations. Breath-by-breath gas exchange measure-
ments were interpolated second-by-second. Values of gas
exchange at rest were derived from the final 2 min of the
resting period. Maximal exercise gas exchange was calcu-
lated from the final 30 s of the incremental exercise test. The
LAT was determined by the “V-slope” method of Beaver et
al. (19).
CURVE FITTING OF V˙O2, HEART RATE AND V˙CO2 RESPONSES.
The V˙O2, heart rate and V˙CO2 responses obtained during
the constant work rate tests were fitted to single exponential
models.
A) EXERCISE. This was a single compartment exponential
type model with incorporation of a variable time-delay at
the beginning (Fig. 1):
f~t)5c1A(12e2(t2td)/t),
where f(t) represents the value of the function after t
minutes of exercise, c is the preexercise value, A represents
the amplitude from baseline of the asymptotic value to
which the function rises, td is the delay before the expo-
nential function commences and t is the time constant. The
longer the time constant, the slower the kinetics of the
variable under consideration. Nonlinear regression analysis
(BMDP statistical software package; BMDP, Los Angeles,
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California) was used to select values for A, c, td and t so as
to achieve a minimum residual sum of squares. Mean
response time (MRT) was defined as t 1 td.
Previous work has suggested that a more sophisticated
three-compartment exponential model may describe the rise
in V˙O2 more precisely (20). We experimented with this
model, but found that it was much more sensitive to “noise”
in the data, and therefore less robust than the single
exponential model.
B) RECOVERY. A single exponential model was again used:
f~t)5c1Ae2(t2td)/t,
where in this case, f(t) represents the value of the function
after t minutes of recovery, c is the asymptotic value at the
end of recovery, A represents the amplitude of the response,
td is the delay before the exponential function commences
and t is the time constant.
OXYGEN DEFICIT AND EPOC. Oxygen deficit was derived by
subtraction of the cumulative V˙O2 for the whole exercise
period from the perceived total O2 requirement. The
average V˙O2 during the final 30 s of exercise was assumed
to represent the V˙O2 appropriate to the exercise intensity.
The perceived total O2 requirement was therefore calculated
by multiplying the V˙O2 at the end of exercise by the exercise
duration (Fig. 2). Excess postexercise oxygen consumption
was derived by calculating the cumulative V˙O2 during
recovery and subtracting the expected cumulative resting
V˙O2 for the same period. The expected cumulative resting
V˙O2 was calculated by multiplying the average preexercise
resting V˙O2 during the final 2 min of rest by the duration of
the recovery period (Fig. 2).
Lactate and methemoglobin. Blood samples were drawn
into heparinized syringes during the resting period just
before exercise began, during the final 30 s of each constant
work rate exercise period and after 3 min of recovery.
Samples were held on ice for no more than 20 min before
analysis. Plasma lactate was measured using a rapid analyzer
(Yellow Springs Instrument Co., Yellow Springs, Ohio).
We determined the coefficient of variation for the assay to
be 2.4%. Methemoglobin concentration was measured in
whole blood using a CO-Oximeter (Instrumentation Lab-
oratories, Lexington, Massachusetts).
Figure 1. Data from a patient with PPH with illustration of the components of the single-exponential curves used to describe the exercise and recovery
responses. In each case, the exponential function starts after a time delay. Exercise: V˙O2 5 c 1 A(1 2 e
-(t 2 td)/t), where c is preexercise baseline V˙O2;
A is amplitude from baseline to asymptotic value; td is time delay; and t is time constant. Recovery: V˙O2 5 c 1 Ae
-(t 2 td)/t, where c is end-recovery
asymptotic V˙O2; A is amplitude of response; td is time delay; and t is time constant.
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Other statistical analyses. Differences among groups were
assessed using one-way analysis of variance (ANOVA)
(Table 3) and two-way ANOVA with repeated measures
(Table 2). Post-hoc significance testing was performed
using the Tukey correction. With the two-way ANOVA,
groups were compared at each time point if the interaction
was significant. Relationships between variables were as-
sessed by computing the correlation coefficient (r), and,
where appropriate, by regression analysis performed using
the least-squares method. The level of statistical significance
was taken as 0.05 throughout.
RESULTS
There were no adverse events during exercise and all tests
were completed according to the protocol.
Incremental test. Peak exercise work rate, V˙O2max and the
LAT were markedly lower in the patients than in the
normals (Table 1).
Constant work rate tests. There was no significant rise in
methemoglobin concentration in the patients after breath-
ing the NO mixture (before NO, 0.46 6 0.36%; at end of
NO study, 0.54 6 0.41%). Right ventricular systolic pres-
sure was elevated in all PPH patients at rest. After breathing
NO at 20 ppm for 15 min at rest, there was a modest fall
from 83.8 6 16.9 to 73.9 6 21.6 mm Hg, p , 0.01
(two-way ANOVA with Tukey correction). No significant
change in RVSP was observed in the control study breath-
ing air (from 88.0 6 20.8 to 86.7 6 20.6 mm Hg).
Responses to exercise are shown in Tables 2 and 3.
Marked differences were observed between the normal
subjects and the patients with PPH. Within the PPH
patients, however, gas exchange responses did not differ
significantly between those experiments breathing air and
those breathing NO. There was a small decrease in heart
rate and increase in O2 pulse with NO breathing (Table 2)
compared with air breathing, but the differences did not
achieve statistical significance.
The patients indicated much higher scores of perceived
exertion than the normal subjects. Heart rate, V˙E, V˙CO2,
O2 pulse and the respiratory exchange ratio (R) at the end
of the exercise bout were also much greater in the patients.
There was a trend towards an increased resting V˙O2 in the
patient group compared with the normal subjects. However,
V˙O2 was similar in patients and normal subjects at the end
of the exercise period. By 3 min of recovery, V˙O2 had
returned to resting values in the normal subjects, but not in
the patients. There was a fall in oxyhemoglobin saturation
in the PPH patients but not in the normal subjects.
End-tidal O2 was higher and end-tidal CO2 was lower in
patients at the end of exercise than at rest, while the
converse was true in the normal subjects (Table 2).
Figure 2. Illustration of the calculation of O2 deficit and EPOC in a patient with PPH. Excess postexercise oxygen consumption (EPOC) was calculated
for a recovery period of 10 min.
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Analysis of kinetics, O2 deficit and EPOC. Substantial
intergroup differences were observed in the kinetics of V˙O2
increase in response to exercise (Table 3). In normal
subjects, there was a rapid increase in V˙O2 at the onset of
exercise, with early achievement of a plateau. In contrast, in
PPH patients, V˙O2 rose slowly and in most patients did not
appear to reach a plateau before the termination of exercise.
Fitting of the single exponential model to the V˙O2 data
resulted in a much longer t and MRT in the patients than
in the normal subjects, although the amplitude of the
response was similar in both groups (Table 3). The recovery
curve-fits also demonstrated much slower kinetics in the
patients than in the normal subjects. The time delay before
commencement of the exponential function in the recovery
process was longer in the patients than in the normal
subjects. The t and MRT values obtained for exercise were
similar to those for recovery (Table 3). In addition, there
was a significant overall correlation between the t values for
exercise and recovery (r 5 0.68, p , 0.0001) and between
the MRT values for exercise and recovery (r 5 0.73, p ,
0.0001). Both O2 deficit and EPOC were greater in the
patients than in the normal subjects (Table 3). In both
groups, the EPOC after 10 min was significantly greater
than the corresponding O2 deficit, but there was a
significant positive correlation between the two variables
(Fig. 3).
The kinetics of heart rate increase and decrease with
exercise and recovery were qualitatively similar to the
V˙O2 responses. There was no significant intergroup
difference in the speed of rise of V˙CO2 during exercise,
Table 2. Gas Exchange and Hemodynamic Variables After Breathing the Test Gas Mixture at Rest, at the End of the 6-Minute
Exercise Period and After 3 Minutes of Resting Recovery
Normals (Air) PPH Air PPH NO
Borg score end 1.4 6 0.9 4.8 6 1.8‡ 5.1 6 2.2‡
V˙O2 (liters/min) rest 0.28 6 0.06 0.32 6 0.09 0.35 6 0.12‡
end 0.97 6 0.20† 0.94 6 0.20† 0.96 6 0.20†
rec 0.27 6 0.04 0.39 6 0.08*§ 0.40 6 0.10§
V˙CO2 (liters/min) rest 0.24 6 0.05 0.28 6 0.08 0.30 6 0.10
end 0.86 6 0.23† 0.96 6 0.21† 0.99 6 0.19†‡
rec 0.26 6 0.03 0.42 6 0.09†§ 0.41 6 0.11†§
Heart rate (beats/min) rest 79 6 15 92 6 13§ 89 6 16‡
end 108 6 19† 132 6 12†§ 130 6 15†§
rec 81 6 17 101 6 13§ 97 6 17§
O2 pulse (ml/beat) rest 3.8 6 1.5 3.5 6 1.0 3.9 6 1.3
end 9.4 6 3.1† 7.2 6 1.5†‡ 7.5 6 1.5†‡
rec 3.6 6 1.3 3.9 6 0.8 4.1 6 0.9
R rest 0.92 6 0.057 0.87 6 0.11 0.86 6 0.07
end 0.92 6 0.10 1.03 6 0.07†§ 1.04 6 0.05†§
rec 1.00 6 0.09* 1.08 6 0.13† 1.04 6 0.10†
Venous lactate (plasma; mmol/liter) rest 1.5 6 0.8 1.0 6 0.3
end 2.7 6 1.3† 2.2 6 1.1†
rec 2.6 6 1.2† 2.4 6 1.0†
V˙E (liters/min) rest 11.9 6 2.4 14.3 6 3.0 14.7 6 4.3
end 28.9 6 5.1† 43.1 6 7.0†§ 45.5 6 8.3†§
rec 13.0 6 1.8 20.2 6 2.2†§ 19.7 6 3.4*§
Respiratory rate (per min) rest 15.1 6 3.7 18.4 6 4.3 17.7 6 4.0
end 20.6 6 6.1 28.5 6 5.2†§ 30.2 6 6.5†§
rec 15.3 6 4.6 21.0 6 5.0‡ 18.6 6 3.6
V˙E/V˙CO2 rest 47.4 6 8.3 53.1 6 8.5 50.6 6 8.3
end 32.7 6 3.5† 45.5 6 7.3*§ 46.7 6 10.0§
rec 48.3 6 6.6 49.3 6 6.7 48.9 6 7.2
V˙E/V˙O2 rest 43.4 6 7.4 45.5 6 7.3 43.3 6 7.3
end 30.1 6 4.2† 46.5 6 7.2§ 48.3 6 10.8§
rec 48.3 6 6.3 52.7 6 6.7* 50.5 6 6.2*
End-tidal CO2 (mm Hg) rest 36.8 6 3.2 30.7 6 3.6§ 30.9 6 4.3§
end 42.9 6 2.6† 29.3 6 4.5§ 28.7 6 5.4§
rec 37.8 6 2.1 30.2 6 3.1§ 30.7 6 3.4§
End-tidal O2 (mm Hg) rest 101.4 6 4.6 108.6 6 6.1§ 108.2 6 5.8§
end 95.4 6 5.9† 113.6 6 5.3*§ 114.6 6 5.5†§
rec 103.3 6 2.7 114.2 6 2.6*§ 113.3 6 2.1*§
SpO2 (%) rest 94.2 6 2.3 (n 5 6) 95.3 6 2.1 93.0 6 2.2
end 95.3 6 2.1 (n 5 6) 89.9 6 4.1†§ 87.9 6 4.8†§
rec 95.7 6 1.8 (n 5 6) 96.2 6 2.9 94.3 6 1.9
Data are mean 6 SD. *p , 0.05. †p , 0.01 vs. corresponding rest value. ‡p , 0.05. §p , 0.01 vs. value in normals at same time-point, two-way analysis of variance with Tukey
test.
NO 5 nitric oxide; PPH 5 primary pulmonary hypertension; R 5 respiratory exchange ratio (V˙CO2/V˙O2); SpO2 5 hemoglobin saturation measured by pulse oximetry;
V˙E 5 minute ventilation; V˙CO2 5 minute carbon dioxide production; V˙O2 5 minute oxygen consumption.
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although the amplitude of the response was greater in the
patients than the normal subjects. During recovery,
V˙CO2 fell more slowly in the patients than in the normal
subjects (Table 3).
DISCUSSION
We have demonstrated marked differences between patients
with PPH and normal subjects in their responses to the
same absolute constant work rate exercise. At the end of the
exercise bout, the patients had much greater physiological
stress than the normal subjects, as shown by their higher
heart rate, lower O2 pulse and higher respiratory exchange
ratio (Table 2). The V˙O2 at the end of exercise was similar
in the two groups, but this was achieved much more slowly
in the patients than in the normal subjects. This is quanti-
fied by the curve-fit parameters, with patients having a
similar amplitude of response to normal subjects, but a
much longer exponential time constant. The inhalation of
NO in the PPH patients caused a modest, but significant,
fall in RVSP gradient at rest. The apparent hemodynamic
improvement was not translated into any significant change
in exercise response.
Physiological stress. An abnormally elevated heart rate
and depressed O2 pulse in response to a given absolute work
rate characteristically occur in subjects with circulatory
disease or deconditioning (3,21). Low stroke volume is
Table 3. Curve-fit Parameters of the V˙O2, V˙CO2 and Heart Rate Responses and O2 Deficit
and EPOC During Exercise and Recovery in Normal Subjects and Patients with PPH Breathing
Air and Air Supplemented With NO 20 ppm
Normals (Air) PPH Air PPH NO
Exercise
V˙O2
c (liters/min) 0.30 6 0.05 0.35 6 0.09 0.34 6 0.09
td (s) 2.90 6 6.65 1.18 6 2.98 3.54 6 5.08
A (liters/min) 0.65 6 0.16 0.61 6 0.14 0.61 6 0.13
t (s) 29.83 6 15.58 61.99 6 13.59† 58.06 6 15.66†
MRT (s) 32.73 6 14.79 63.17 6 14.99† 61.60 6 15.45†
O2 deficit (liters) 0.34 6 0.22 0.73 6 0.21† 0.72 6 0.23†
V˙CO2
c (liters/min) 0.27 6 0.03 0.30 6 0.09 0.29 6 0.07
td (s) 2.7 6 6.8 4.0 6 7.3 3.7 6 4.8
A (liters/min) 0.63 6 0.17 0.71 6 0.19 0.73 6 0.18*
t (s) 64.0 6 42.5 73.7 6 20.8 75.0 6 31.5
MRT (s) 66.7 6 41.0 77.7 6 22.6 78.7 6 32.8
Heart rate
c (beats/min) 79 6 15 93 6 13 89 6 15
td (s) 2.4 6 2.2 0.0 6 0.0 1.5 6 3.3
A (beats/min) 28 6 6 40 6 13* 41 6 13
t (s) 22.3 6 21.0 79.5 6 38.4* 87.1 6 55.5†
MRT (s) 24.7 6 19.4 79.5 6 38.4† 88.6 6 54.7†
Recovery
V˙O2
c (liters/min) 0.27 6 0.04 0.35 6 0.08† 0.35 6 0.09†
td (s) 20.42 6 3.68 16.98 6 11.44† 15.98 6 13.54†
A (liters/min) 0.69 6 0.17 0.62 6 0.15 0.61 6 0.14*
t (s) 34.17 6 8.55 65.52 6 26.53† 57.38 6 6.71*
MRT (s) 34.59 6 7.11 82.50 6 29.94† 73.36 6 15.87†
EPOC at 10 min (liters) 0.52 6 0.18 0.98 6 0.22† 0.96 6 0.20†
V˙CO2
c (liters/min) 0.25 6 0.04 0.31 6 0.07† 0.31 6 0.07†
td (s) 0.0 6 6.0 2.5 6 5.3 7.8 6 13.8
A (liters/min) 0.64 6 0.18 0.69 6 0.17 0.68 6 0.15
t (s) 46.2 6 16.6 100.5 6 24.6* 75.0 6 32.0
MRT (s) 46.2 6 16.6 100.5 6 24.6† 82.7 6 24.5†
Heart rate
c (beats/min) 81 6 16 98 6 13* 94 6 17
td (s) 5.7 6 6.5 16.8 6 17.5 17.3 6 12.9
A (beats/min) 27 6 7 36 6 12 35 6 12
t (s) 16.3 6 12.1 69.6 6 36.5† 58.1 6 28.1†
MRT (s) 22.0 6 9.0 86.4 6 37.3† 75.4 6 26.5†
Data are mean 6 SD. *p , 0.05. †p , 0.01 vs. normals, analysis of variance with Tukey test.
Curve-fit parameters: c 5 baseline value; td 5 time delay before commencement of exponential component; A 5 amplitude
of response; t 5 time constant of exponential response; MRT 5 mean response time (MRT 5 td 1 t); EPOC 5 excess
postexercise oxygen consumption; NO 5 nitric oxide; PPH 5 primary pulmonary hypertension; V˙CO2 5 minute carbon dioxide
production; V˙O2 5 minute oxygen consumption.
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probably the main factor responsible. Stroke volume is
abnormally low in PPH and fails to increase with exercise
(22). In PPH (23) and chronic heart failure (24,25), the
systemic extraction of O2 during exercise is at least as
efficient as in normals. In contrast to chronic heart failure
(26), however, we found reduced SpO2 levels in our patients
with PPH. This desaturation could have resulted in a
reduced arteriovenous O2 difference, although we did not
measure mixed venous or femoral O2 content. Slightly
higher hemoglobin concentrations in the patients than in
the normal subjects (Table 1) may have partially compen-
sated for the arterial desaturation.
The respiratory exchange ratio (R) at peak exercise was
much greater in the PPH patients than the normal subjects,
and suggests an increased reliance on carbohydrate as a
substrate in skeletal muscle and/or increased buffering of
lactic acid by bicarbonate (27). It is unlikely to be accounted
for by hyperventilation, because end-tidal CO2 did not
decrease from resting values during exercise. The work rate
performed was much greater as a proportion of maximal
work rate in the patients than in the normal subjects. As
relative work rate increases, whole-body R tends to increase
reflecting an increase in overall carbohydrate oxidation and
a decrease in lipid oxidation (27,28). However, aerobic
metabolism alone cannot lead to an R of .1.0. Because R
was .1.0 at the end of exercise in the PPH patients, this
implies that ongoing buffering of lactic acid was also
significant and that a true steady-state had not been
achieved (29).
Minute ventilation was greater in the PPH patients than
in the normals at the end of exercise. This was accompanied
by greater ventilatory equivalents for O2 and CO2, and by
lower end-tidal CO2 and greater end-tidal O2. Taken
together with the fall in SpO2 in the PPH patients, these
findings imply decreased ventilatory efficiency. Several fac-
tors may account for this increased ventilatory response (30).
1) To compensate for an impaired right ventricular output
response, a lactic acidosis would develop at a low work rate.
This would drive ventilation and reduce the arterial CO2
set-point. In turn, a greater V˙E is necessary to achieve the
same V˙CO2. The partial pressure of CO2 in arterial blood
has been shown to be low in PPH (2). 2) Shunting of
pulmonary arterial blood may occur, either through a patent
foramen ovale or intrapulmonary channels. Dantzker and
colleagues (31) applied the multiple inert gas technique to a
group of patients with chronic obliterative pulmonary hy-
pertension and found variable increases in veno-arterial
shunt at rest, with values ranging from 4% to 24% of cardiac
output. Such right-left shunting would result in a fall in the
partial pressure of O2 in arterial blood and stimulate the
carotid chemoreceptors, resulting in increased ventilatory
drive. Our patient with the proven patent foramen ovale had
the most marked fall in SpO2. 3) A true increase in
physiological dead space/tidal volume ratio could occur
because the underlying disease reduces perfusion to venti-
lated lung. Thus, particularly during exercise, when new
capillary bed is normally recruited, acini may remain under-
perfused in PPH.
Kinetic responses. The kinetics of change in V˙O2 with
onset of exercise were much slower in the PPH patients
than in the normal subjects. From the Fick equation, this
implies that cardiac output and/or arteriovenous O2 differ-
ence increased at a slower rate in the patients than in the
normal subjects. We know of no studies that have examined
the dynamics of either of these components invasively in
PPH. However, the elevated pulmonary arterial resistance
in PPH appears to constrain the increase in cardiac output
with exercise (22). Additionally, as discussed above, periph-
eral O2 extraction appears normal, or even excessive in
PPH, with very low mixed venous O2 saturation being
observed during exercise (23). These observations would
favor cardiac output limitation as the cause for the slow
kinetics. Our finding of slowed heart rate kinetics in PPH is
also consistent with the view that the abnormal cardiac
output response is primarily responsible for the slow rise in
V˙O2. In the absence of continuous measurements of arte-
riovenous O2 difference, we cannot exclude peripheral
abnormalities as a factor in the delayed V˙O2 kinetics in
PPH. In chronic heart failure, skeletal muscle abnormalities
occur, including reduced mitochondrial density and aerobic
enzyme capacity (32). If similar changes were present in
PPH, they could contribute to the slow rise in V˙O2.
The time course of the recovery process was also pro-
longed in PPH and there was a close correlation between
the kinetics of the exercise and recovery V˙O2. These
observations suggest that the factors governing the rise in
V˙O2 with exercise, as discussed above, are closely related to
those controlling its decline during recovery. The relation-
ship between exercise and recovery kinetics is mirrored in
Figure 3. Excess postexercise oxygen consumption (EPOC) plotted as a
function of O2 deficit in PPH patients breathing air and breathing NO and
in normals breathing air. The line of identity is shown by the dashed line.
The combined line of regression is illustrated by the solid line. (EPOC 5
0.87(O2 deficit) 1 0.31, r 5 0.84, p , 0.0001).
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the relationship between O2 deficit and EPOC (Fig. 3). In
the PPH patients, there was a longer time delay before
commencement of the exponential phase of declining V˙O2
during recovery than in the normal subjects. This may
represent a period during which the V˙O2 appropriate to the
intracellular state is greater than can be delivered by the
circulation.
The kinetics of the increase in V˙CO2 with exercise were
not significantly different in the PPH patients compared
with the normal subjects, but the decrease during recovery
was much slower in the patients. Buffering of increased
amounts of lactic acid early during exercise is likely to have
resulted in the augmentation of CO2 produced by the slowly
increasing aerobic mechanisms in the patients. Conversely,
during recovery, persistent acidosis could have accounted for
the continuing production of buffer CO2, thus prolonging
further the slow decline in V˙CO2 attributable to aerobic
processes.
Oxygen deficit and EPOC. The O2 deficit incurred dur-
ing the exercise bout was greater in patients than in normal
subjects. This is a direct consequence of the slower V˙O2
kinetics in the patients, because the V˙O2 at the end of
exercise was similar in both groups, and the resting V˙O2, if
anything, was slightly greater in patients. Magnetic reso-
nance spectroscopy studies in chronic heart failure patients
suggest that ATP and phosphocreatine (PCr) depletion are
greater than in normal subjects at the same absolute exercise
intensity (33). If the same biochemical abnormalities are
present in PPH, this implies that the large O2 deficit is
associated with similar excess depletion of high-energy
compounds. The EPOC after 10 min of recovery was also
greater in the patients than in the normal subjects. While
the EPOC was systematically greater than the O2 deficit,
there was nonetheless a significant positive correlation.
During early recovery, postexercise V˙O2 and resynthesis of
PCr have been found to follow a similar time course (34).
This suggests that the early phase of EPOC is due to PCr
repletion, and our finding of a correlation between EPOC
and O2 deficit is consistent with this hypothesis. Restora-
tion of oxyhemoglobin saturation to resting levels in PPH is
also likely to contribute to the significantly increased
EPOC.
In normal subjects, when EPOC is measured over periods
of an hour or more, there appears to be little relationship
between it and the O2 deficit. After the early recovery
period, other factors, such as elevated catecholamines, fatty
acids and temperature, may become important in the
causation of the EPOC (8). These factors probably bear a
less direct relationship than PCr depletion to the conditions
of the preceding exercise bout.
In calculating the O2 deficit, we have assumed that the
end-exercise V˙O2 is the V˙O2 appropriate to the work rate
being performed. However, during heavy constant work rate
exercise, it is known that the V˙O2 does not reach a
steady-state before the end of exercise (35). It is likely that
this situation pertained in our PPH patients. For this
reason, the end-exercise V˙O2 may be a slight underestimate
of the V˙O2 appropriate to the work rate in the PPH
patients. It follows that our estimation of O2 deficit is likely
to be somewhat low in the patients.
Effect of NO. We were unable to demonstrate a change in
any of the exercise responses with NO breathing, despite a
modest reduction in RVSP at rest. As all patients remained
on their usual medications, any positive effect of NO is
likely to have been less than if NO had been administered
alone. In addition, we did not obtain Doppler estimations of
RVSP during exercise or measure hemodynamics directly.
We cannot be certain that NO improved pulmonary vascu-
lar resistance or cardiac output during exercise.
Summary. Severe gas exchange abnormalities occur during
exercise and recovery in patients with PPH. In particular,
there is slowing of V˙O2 kinetics with excessive O2 deficit
and EPOC. These abnormalities persist despite a modest
acute improvement in RVSP gradient resulting from NO
inhalation.
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